Felipe Bisbal

Felipe Bisbal

Auto-generated profile, based on publicly available information

Felipe Bisbal

ICREC Research Program, Germans Trias i Pujol Research Institute (IGTP), Badalona, Barcelona, Spain; Heart Institute (iCOR), Germans Trias i Pujol University Hospital, Badalona, Barcelona, Spain; CIBER Cardiovascular, Instituto de Salud Carlos III, Madrid, Spain

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 October 2013 in European Heart Journal
Verified
Journal Article
Open access
PDF file
LMLluís Mont
Lluís Mont
FBFelipe Bisbal
Felipe Bisbal
AHAntonio Hernández-Madrid
Antonio Hernández-Madrid
NPNicasio Pérez-Castellano
Nicasio Pérez-Castellano
XVXavier Viñolas
Xavier Viñolas
JBJosep Brugada
Josep Brugada
Catheter ablation (CA) is a highly effective therapy for the treatment of paroxysmal atrial fibrillation (AF) when compared with antiarrhythmic drug therapy (ADT). No randomized studies have compared the two strategies in persistent AF. The present randomized trial aimed to compare the effectiveness of CA vs. ADT in treating persistent AF. Patients with persistent AF were randomly assigned to CA or ADT (excluding patients with long-standing persistent AF). Primary endpoint at 12-month follow-up was defined as any episode of AF or atrial flutter lasting >24 h that occurred after a 3-month blanking period. Secondary endpoints were any atrial tachyarrhythmia lasting >30 s, hospitalization, and electrical cardioversion. In total, 146 patients were included (aged 55 ± 9 years, 77% male). The ADT group received class Ic (43.8%) or class III drugs (56.3%). In an intention-to-treat analysis, 69 of 98 patients (70.4%) in the CA group and 21 of 48 patients (43.7%) in the ADT group were free of the primary endpoint (P = 0.002), implying an absolute risk difference of 26.6% (95% CI 10.0–43.3) in favour of CA. The proportion of patients free of any recurrence (>30 s) was higher in the CA group than in the ADT group (60.2 vs. 29.2%; P < 0.001) and cardioversion was less frequent (34.7 vs. 50%, respectively; P = 0.018). Catheter ablation is superior to medical therapy for the maintenance of sinus rhythm in patients with persistent AF at 12-month follow-up. NCT00863213 (http://clinicaltrials.gov/ct2/show/NCT00863213).

1 January 2020 in JACC
Verified
Journal Article
Open access
FBFelipe Bisbal
Felipe Bisbal
ABAdrian Baranchuk
Adrian Baranchuk
EBEugene Braunwald
Eugene Braunwald
ALAntoni Bayés de Luna
Antoni Bayés de Luna
ABAntoni Bayes
Antoni Bayes
Atrial dysfunction has been widely considered a marker or consequence of other cardiac conditions rather than the cause itself. Here, we propose the term atrial failure as a clinically relevant entity, defined as any atrial dysfunction causing impaired heart performance, symptoms, and worsening quality of life or life expectancy. Aspects of the etiology, mechanisms, and consequences of atrial failure are discussed. Recent advances in cardiac electrophysiology and imaging have improved our understanding of the highly complex atrial anatomy and function, underlying the paramount importance of the atria in optimal heart performance. It is time to reappraise the concept of the failing atrium as a primary cause or aggravating factor of the symptoms in many of our patients. The concept of atrial failure may foster basic and translational research to gain a better understanding of how to identify and manage atrial dysfunction.

14 March 2013 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Closed access
FBFelipe Bisbal
Felipe Bisbal
EGEsther Guiu
Esther Guiu
NCNaiara Calvo
Naiara Calvo
DMDavid Marin
David Marin
ABAntonio Berruezo
Antonio Berruezo
LMLluís Mont
Lluís Mont

9 December 2016 in EP Europace
Verified
Journal Article
Closed access
PDF file
EBEva M. Benito
Eva M. Benito
ACAlicia Carlosena-Remirez
Alicia Carlosena-Remirez
EGEduard Guasch
Eduard Guasch
SPSusana Prat-González
Susana Prat-González
RPRosario J. Perea
Rosario J. Perea
LMLluis Mont
Lluis Mont
Identification of left atrial (LA) fibrosis through late gadolinium-enhanced cardiac magnetic resonance (LGE-CMR) remains controversial due to the heterogeneity and lack of reproducibility of proposed methods. Our aim is to describe a normalized, reproducible, standardized method to evaluate LA fibrosis through LGE-CMR. Electrocardiogram- and respiratory-gated 3-Tesla LGE-CMR was performed in 10 healthy young volunteers and 30 patients with atrial fibrillation (AF): 10 with paroxysmal AF, 10 with persistent AF, and 10 with a previous AF ablation procedure. Local image intensity ratio (IIR) of the LA was calculated as the absolute pixel intensity to mean blood pool intensity ratio. The healthy atrial tissue threshold was defined in young healthy volunteers (upper limit of normality set at IIR tissue mean plus 2 SDs). Dense atrial scarring was characterized in patients with previous radiofrequency-induced scarring (post-AF ablation patients). Validation groups consisted of patients with paroxysmal and persistent AFs. The upper limit of normal IIR was 1.20; IIR values higher than 1.32 (60% of mean maximum pixel intensity in post-ablation patients) were considered dense scar. Image intensity ratio values between 1.2 and 1.32 identified interstitial fibrosis. Patients with paroxysmal and persistent AFs had less atrial fibrotic tissue compared with post-ablation patients. Endocardial bipolar voltage was correlated to IIR values. An IIR of 1.2 identifies the upper limit of normality in healthy young individuals. An IIR of >1.32 defines dense atrial fibrosis in post-ablation patients. Our results provide a consistent, comparable, and normalized tool to assess atrial arrhythmogenic substrate.

1 September 2015 in EP Europace
Verified
Journal Article
Open access
PDF file
NCNaiara Calvo
Naiara Calvo
PRPablo Ramos
Pablo Ramos
SMSilvia Montserrat
Silvia Montserrat
EGEduard Guasch
Eduard Guasch
BCBlanca Coll-Vinent
Blanca Coll-Vinent
LMLluís Mont
Lluís Mont
The role of high-intensity exercise and other emerging risk factors in lone atrial fibrillation (Ln-AF) epidemiology is still under debate. The aim of this study was to analyse the contribution of each of the emerging risk factors and the impact of physical activity dose in patients with Ln-AF. Patients with Ln-AF and age- and sex-matched healthy controls were included in a 2:1 prospective case–control study. We obtained clinical and anthropometric data transthoracic echocardiography, lifetime physical activity questionnaire, 24-h ambulatory blood pressure monitoring, Berlin questionnaire score, and, in patients at high risk for obstructive sleep apnoea (OSA) syndrome, a polysomnography. A total of 115 cases and 57 controls were enrolled. Conditional logistic regression analysis associated height [odds ratio (OR) 1.06 [1.01–1.11]], waist circumference (OR 1.06 [1.02–1.11]), OSA (OR 5.04 [1.44–17.45]), and 2000 or more hours of cumulative high-intensity endurance training to a higher AF risk. Our data indicated a U-shaped association between the extent of high-intensity training and AF risk. The risk of AF increased with an accumulated lifetime endurance sport activity ≥2000 h compared with sedentary individuals (OR 3.88 [1.55–9.73]). Nevertheless, a history of <2000 h of high-intensity training protected against AF when compared with sedentary individuals (OR 0.38 [0.12–0.98]). A history of ≥2000 h of vigorous endurance training, tall stature, abdominal obesity, and OSA are frequently encountered as risk factors in patients with Ln-AF. Fewer than 2000 total hours of high-intensity endurance training associates with reduced Ln-AF risk.

1 April 2018 in JACC: Cardiovascular Imaging
Verified
Journal Article
Closed access
JAJuan Acosta
Juan Acosta
JFJuan Fernández-Armenta
Juan Fernández-Armenta
RBRoger Borràs
Roger Borràs
IAIgnasi Anguera
Ignasi Anguera
FBFelipe Bisbal
Felipe Bisbal
ABAntonio Berruezo
Antonio Berruezo